Th9 cells are known to elicit strong host antitumor CD8+ cytotoxic T lymphocyte (CTL) responses by promoting Ccl20/Ccr6-dependent recruitment of dendritic cells to tumor tissues via IL-9 production [40]. This evidence concerns the gene CCR6 and neoplasm.